[Prevention of herpes zoster by vaccination].
Dermato-venerologisk Afdeling D41, Bispebjerg Hospital, 2400 København NV, Denmark.Ugeskrift for laeger 01/2011; 173(2):110-4.
Herpes zoster (HZ) and post-herpetic neuralgia (PHN) are frequently occurring diseases in elderly and in immuno-compromised persons. The live attenuated HZ vaccine boosts an existing immune response, so that the already established varicella-zoster virus infection is kept latent. Vaccination has been shown to halve the risk of HZ, and the risk of PHN is reduced by two thirds in people = 60 years. The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects.
- [Show abstract] [Hide abstract]
ABSTRACT: Objective: Varicella is an important viral infection. It can present with acute febrile illness with rash. In some case, the rare complication as varicella pneumonia can be seen. Methods: This work is a retrospective study. The meta-analysis of previously documented papers was done. Results: The clinical characteristics of documented Thai cases were summarized and presented. Conclusions: In this specific report, the authors summarize on the previous reports on varicella pneumonia from Thailand, a tropical country where high rate of varicella infection can be observed.Asian Pacific Journal of Tropical Biomedicine 12/2012; 2(3):S1867-S1868. DOI:10.1016/S2221-1691(12)60510-3
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.